Citi analyst Mathieu Chevrier upgraded Pro Medicus to Neutral from Sell with an unchanged price target of A$61. The analyst cites the recent decline in the shares for the upgrade.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PMCUF:
